OXFORD, England, March 30, 2015 /PRNewswire/ —
Internationally renowned quality seal recognises leading medical device manufacturer in the area of product design
With its unique integrated disposal chamber, the Unifine® Pentips® has been carefully designed to encourage more frequent needle change and to reduce penetration and glide forces for a more comfortable injection experience. The medical device manufacturer won the award within the Product Design category which saw a total of 4,928 entries, from 56 countries, judged by a panel consisting of respected design professors, designers and specialist journalists.
Jarl Severn, CEO of Owen Mumford, commented, "We are both delighted and immensely proud to have been chosen for such a world renowned award for design. We have always focused on designing the next ‘big idea’ and have invested significantly in our Research and Development capabilities to support this." Severn continued, "Our mission is to provide solutions that will exceed expectations, encourage adherence and improve quality of life; the Unifine® Pentips® Plus pen needle is a great demonstration of this, right from initial design concept through to manufacture."
Richard Walker, Global Product Manager for Drug Delivery Products, added, "The initial concept behind Unifine® Pentips® Plus was to make the injection process as easy and comfortable for the end-user as possible, which plays an integral part in encouraging good self-management practices. The research and design team went back to the drawing board to create a completely new solution for the long established, standard insulin pen needle market sector. Unifine® Pentips® Plus is proven  to encourage better needle change behaviour and for our design to be recognised by the judging panel at Red Dot, is great news."
The Unfine® Pentips® Plus pen needle is available in a range of lengths from 4mm 32G to 12mm 29G and available for sale in Europe, North America and Asia with our local China office launching Unifine® Pentips® Plus to their market this month.
For further information visit www.owenmumford.com
1. 2013 Independent study by Healthcare Research Worldwide: The impact of Unifine® Pentips® Plus on needle changing behaviour. 2014 Independent Melab GmbH Test Data.
About Owen Mumford
Owen Mumford is a major medical device manufacturer that develops pioneering medical devices for its own Owen Mumford brand and custom device solutions for the world’s major pharmaceutical and diagnostic companies. Owen Mumford’s goal is to improve quality of life, encourage adherence to treatment and reduce healthcare costs. Making a world of difference, to a world of people.
With a history of world firsts in device solutions, Owen Mumford offers proven design, development and delivery services from a broad base of proven self-injection and blood sampling platform devices and intellectual property.
In business for over 60 years, Owen Mumford remains privately owned with a focus on long-term investment to deliver sustainable business growth. With a strong internal research and development capability, Owen Mumford’s goal is to develop solutions that address today’s healthcare demands. Through advanced research involving end-users and health care professionals, and extensive design and manufacturing capabilities, Owen Mumford produces class-leading medical devices that are used by a global audience – exporting over 85% of its products to more than 60 countries worldwide.
Selected as one of The World Economic Forum’s Global Growth Companies, Owen Mumford is a trusted partner to many of the world’s biggest medical device and pharmaceutical companies and works with international organisations to support customers at a local level and provide consistent and dedicated care.